These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Abeillon-du Payrat J, Chikh K, Bossard N, Bretones P, Gaucherand P, Claris O, Charrié A, Raverot V, Orgiazzi J, Borson-Chazot F, Bournaud C. Eur J Endocrinol; 2014 Oct; 171(4):451-60. PubMed ID: 25214232 [Abstract] [Full Text] [Related]
3. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. Zakarija M, McKenzie JM. J Clin Endocrinol Metab; 1983 Nov; 57(5):1036-40. PubMed ID: 6137493 [Abstract] [Full Text] [Related]
5. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis. Hoffman WH, Sahasrananan P, Ferandos SS, Burek CL, Rose NR. J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322 [Abstract] [Full Text] [Related]
6. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. Zakarija M, McKenzie JM, Hoffman WH. J Clin Endocrinol Metab; 1986 Feb; 62(2):368-71. PubMed ID: 2867106 [Abstract] [Full Text] [Related]
7. Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring. Chang TC, Lee JS. J Formos Med Assoc; 1990 Aug; 89(8):709-13. PubMed ID: 1981235 [Abstract] [Full Text] [Related]
8. Thyroid-stimulating immunoglobulins and thyroid function tests in two siblings with neonatal thyrotoxicosis. Wit JM, Rees-Smith B, Creagh FM, Bruinse HW, van der Heide D, Docter R, Gerards LJ. Eur J Pediatr; 1986 Apr; 145(1-2):143-7. PubMed ID: 2874029 [Abstract] [Full Text] [Related]
9. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related]
12. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K. J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [Abstract] [Full Text] [Related]
14. Thyroid-stimulating immunoglobulin as a cause of recurrent intrauterine fetal death. Houck JA, Davis RE, Sharma HM. Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1018-9. PubMed ID: 2897651 [Abstract] [Full Text] [Related]
15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [Abstract] [Full Text] [Related]
16. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W, Man N, Li YS, Shan ZY, Teng WP. Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113 [Abstract] [Full Text] [Related]
17. Neonatal thyroid disease: differential expression in three successive offspring. Fort P, Lifshitz F, Pugliese M, Klein I. J Clin Endocrinol Metab; 1988 Mar; 66(3):645-7. PubMed ID: 2895120 [Abstract] [Full Text] [Related]
18. Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report. Kasagi K, Hidaka A, Endo K, Miyamoto S, Takeuchi R, Misaki T, Sakahara H, Konishi J. Thyroid; 1993 Mar; 3(4):315-8. PubMed ID: 7906975 [Abstract] [Full Text] [Related]
19. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T. J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399 [Abstract] [Full Text] [Related]
20. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis. Munro DS, Dirmikis SM, Humphries H, Smith T, Broadhead GD. Br J Obstet Gynaecol; 1978 Nov; 85(11):837-43. PubMed ID: 581471 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]